Is Khyati Multimed. overvalued or undervalued?

Nov 18 2025 08:22 AM IST
share
Share Via
As of November 17, 2025, Khyati Multimed. is considered overvalued with a valuation grade of risky, reflected by a negative PE Ratio of -3.46 and poor performance compared to peers, including a -24.01% return over the past year against the Sensex's 9.50% gain.
As of 17 November 2025, the valuation grade for Khyati Multimed. has moved from very expensive to risky, indicating a significant shift in market perception. The company is currently assessed as overvalued. Key ratios include a PE Ratio of -3.46, an EV to EBITDA of -2.88, and a Price to Book Value of 2.64, which reflect poor financial health and performance.

In comparison to peers, Khyati Multimed. stands out unfavorably against Altius Telecom, which has a PE Ratio of 51.5, and Sagility, with a PE of 29.82. The negative returns of Khyati Multimed. over the past year (-24.01%) contrast sharply with the Sensex's positive return of 9.50%, further emphasizing its overvaluation in the current market context.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News